Project Grant R01AI179712
Award Date
1/17/25
Completion Date
12/31/29
Dollars Obligated
$857K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
This $231,752 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will fund research at the Fred Hutchinson Cancer Center in Seattle, WA to investigate the in vivo mechanisms of the innate immune response to HIV-1 infection. The research aims to identify the cellular sources of cytokines released during acute HIV-1 infection and determine the functional roles of different innate immune...
This $256,500 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research by the Fred Hutchinson Cancer Center in Seattle, Washington, to investigate how regulatory T cells coordinate the mucosal natural killer (NK) cell response during viral infections. The key objectives are to gain a deeper understanding of how regulatory T cells modulate NK cell function and homing...
This $162,512 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand how pathogen exposure and inflammation drive the expansion and function of long-lived effector CD8 T cells in the memory compartment. The key research objectives are to: 1) Determine what pro-inflammatory cytokines support the formation and persistence of long-lived effector CD8 T cells,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) totaling $639,084 to Childrens Hospital Medical Center in Cincinnati, Ohio. The grant, which runs from March 2025 through February 2030, supports research to elucidate the heterogeneity of naive CD8 T cells and understand how this diversity contributes to immune responses and T cell homeostasis in mice. Additionally, the project aims to define a human...
This $320,788 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research at the University of Washington to investigate the role of antigen-independent T cell activation in controlling Mycobacterium tuberculosis (M.tb) infection, which causes tuberculosis (TB). The research aims to determine the ability of CD1a/b/c-restricted T cells to undergo bystander activation and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $237,600.00 to the Fred Hutchinson Cancer Center in Seattle, Washington to characterize a new CXCR4-specific restriction factor and its effect on HIV infection in primary mucosal CD4+ T cells. The research aims to examine how the SLC35A2 gene regulates HIV infection by restricting CXCR4-using (X4) virus strains...
This is a Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The $693,465 award will fund a 5-year research project from January 2025 to December 2029 to Cornell University's Office of Sponsored Programs. The project aims to construct the first molecular atlas of T cell development in lymph nodes and determine how cellular interactions and communication networks change during CD8+...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Emory University a $1,179,316 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct research on T cell responses during chronic viral infections. The goal of the 5-year project is to understand how a novel population of virus-specific stem-like CD8 T cells is generated and maintained during chronic infection, and how this information can be leveraged to optimize PD-1 directed...
This $884,322 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to the Fred Hutchinson Cancer Center supports research to study the mechanisms that create and sustain the HIV reservoir, a population of latently infected cells that persists during suppressive antiretroviral therapy and prevents a cure for HIV. The project will use a mathematical modeling approach to integrate existing and novel...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to better understand the immune and inflammatory responses associated with necroptosis, a form of programmed cell death. The $350,000 award will fund three key objectives: 1) defining the molecular interactions and transcriptional programs activated by necroptosis pathway components in cultured...